How do genes influence the development of chronic idiopathic thrombocytopenic purpura?

Combining treatment options for higher risk myelodysplastic syndromes and chronic myelomonocytic leukaemia

ASH 2015: Highlights in mantle cell lymphoma

Incidence of and predictors for early death in paediatric patients with acute promyelocytic leukaemia

Blinatumomab has promising effect on hard-to-treat, rare acute lymphoblastic leukaemia subtype

Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia

First all-oral treatment for relapsed and treatment-resistant multiple myeloma

Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia

Idelalisib combination therapy in relapsed or treatment-resistant CLL better than standard regimen

ASH 2015: Novel combination approaches for multiple myeloma

ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia

ASH 2015: New targeted therapies for haematological malignancies